Getting to grips with sarcopenia: recent advances and practical management for the gastroenterologist
Getting to grips with sarcopenia: recent advances and practical management for the gastroenterologist
Sarcopenia is a progressive and generalised disorder of skeletal muscle strength, function and mass, that is most commonly associated with the normal ageing process. It is increasingly recognised that sarcopenia can also develop as a consequence of malabsorptive and inflammatory conditions, such as those seen by gastroenterologists and hepatologists. It affects 1%–30% of the general population, but is seen in approximately 40% of patients with gastrointestinal conditions including inflammatory bowel disease and cirrhosis. Within this group of patients, it is associated with increased complications and mortality. The pathogenesis of sarcopenia is multifactorial with several risk factors implicated in its development including undernutrition, physical inactivity and coexistent multimorbidity. The SARC-F questionnaire has been developed to screen for patients at risk of sarcopenia, however, this focuses on the functional consequences and will therefore not identify those patients who are early in the progression of sarcopenia. There are several different non-invasive techniques available to assess muscle quantity and quality including; grip strength, dual energy X-ray absorptiometry, CT which can be used together to diagnose sarcopenia. Assessment and correction of malnutrition, particularly protein intake, in those at risk of sarcopenia is important in preventing the development and progression of sarcopenia. There are no specific drugs that are available for the treatment of sarcopenia, however, resistance exercise programmes combined with nutritional interventions show promise. It is important that this common condition is screened for and recognised, with any contributing factors addressed to reduce the risk of its progression.
nutrition, nutritional status, nutritional support
53-61
Hollingworth, T.
70fd725e-0c58-4028-92c9-20c01b096a5b
Oke, Siddhartha M
87a37b17-dbfd-4bd3-ba29-688d80d0b32c
Patel, Harnish
e1c0826f-d14e-49f3-8049-5b945d185523
Smith, Trevor R.
b8f3e1d2-5b8e-44ee-9b5f-b20ece3da837
January 2021
Hollingworth, T.
70fd725e-0c58-4028-92c9-20c01b096a5b
Oke, Siddhartha M
87a37b17-dbfd-4bd3-ba29-688d80d0b32c
Patel, Harnish
e1c0826f-d14e-49f3-8049-5b945d185523
Smith, Trevor R.
b8f3e1d2-5b8e-44ee-9b5f-b20ece3da837
Hollingworth, T., Oke, Siddhartha M, Patel, Harnish and Smith, Trevor R.
(2021)
Getting to grips with sarcopenia: recent advances and practical management for the gastroenterologist.
Frontline Gastroenterology, 12 (1), .
(doi:10.1136/flgastro-2019-101348).
Abstract
Sarcopenia is a progressive and generalised disorder of skeletal muscle strength, function and mass, that is most commonly associated with the normal ageing process. It is increasingly recognised that sarcopenia can also develop as a consequence of malabsorptive and inflammatory conditions, such as those seen by gastroenterologists and hepatologists. It affects 1%–30% of the general population, but is seen in approximately 40% of patients with gastrointestinal conditions including inflammatory bowel disease and cirrhosis. Within this group of patients, it is associated with increased complications and mortality. The pathogenesis of sarcopenia is multifactorial with several risk factors implicated in its development including undernutrition, physical inactivity and coexistent multimorbidity. The SARC-F questionnaire has been developed to screen for patients at risk of sarcopenia, however, this focuses on the functional consequences and will therefore not identify those patients who are early in the progression of sarcopenia. There are several different non-invasive techniques available to assess muscle quantity and quality including; grip strength, dual energy X-ray absorptiometry, CT which can be used together to diagnose sarcopenia. Assessment and correction of malnutrition, particularly protein intake, in those at risk of sarcopenia is important in preventing the development and progression of sarcopenia. There are no specific drugs that are available for the treatment of sarcopenia, however, resistance exercise programmes combined with nutritional interventions show promise. It is important that this common condition is screened for and recognised, with any contributing factors addressed to reduce the risk of its progression.
This record has no associated files available for download.
More information
Published date: January 2021
Keywords:
nutrition, nutritional status, nutritional support
Identifiers
Local EPrints ID: 454239
URI: http://eprints.soton.ac.uk/id/eprint/454239
ISSN: 2041-4137
PURE UUID: 54fbe36e-65ef-4299-af64-06a7bf11d845
Catalogue record
Date deposited: 03 Feb 2022 17:47
Last modified: 17 Mar 2024 03:09
Export record
Altmetrics
Contributors
Author:
T. Hollingworth
Author:
Siddhartha M Oke
Author:
Harnish Patel
Author:
Trevor R. Smith
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics